The responsibilities of the Administration, Biostatistics, and Data Management Core include support of the individual projects, including their evaluation and integration into the program as a whole. This core will have overall fiscal and scientific responsibility for the entire U19 Project, including employment of key personnel to oversee the efficient running of the program. The specific responsibilities of the core are: 1. To convene all necessary meetings, including meetings of the Executive Committee, External Advisory Committee, and various meetings for scientific exchange. 2. To prepare reports to NCI as well as to fulfill internal reporting requirements. 3. To organize a one-day administrative and research meeting every six months to coordinate program efforts and facilitate informational exchange. 4. To coordinate quality control and quality assurance. 5. To control expenditures and maintain budget information. 6. To prepare all publications, including abstracts and manuscripts, resulting from this research. 7. To provide biostatistical support to all project personnel whenever needed. 8. To provide data management support. 9. To work with principal investigators, research nurses, and laboratory scientists in monitoring the data quality on a regular basis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program--Cooperative Agreements (U19)
Project #
3U19CA068437-04S1
Application #
6103132
Study Section
Project Start
1998-08-01
Project End
1999-07-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
4
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Tam, Alda L; Kim, Edward S; Lee, J Jack et al. (2013) Feasibility of image-guided transthoracic core-needle biopsy in the BATTLE lung trial. J Thorac Oncol 8:436-42
Hittelman, Walter N; Liu, Diane D; Kurie, Jonathan M et al. (2007) Proliferative changes in the bronchial epithelium of former smokers treated with retinoids. J Natl Cancer Inst 99:1603-12
Gu, Jian; Wu, Xifeng; Dong, Qiong et al. (2006) A nonsynonymous single-nucleotide polymorphism in the PDZ-Rho guanine nucleotide exchange factor (Ser1416Gly) modulates the risk of lung cancer in Mexican Americans. Cancer 106:2716-24
Han, Ji-Youn; Liu, Diane D; Lee, J Jack et al. (2005) 9-cis-retinoic acid treatment increases serum concentrations of alpha-tocopherol in former smokers. Clin Cancer Res 11:2305-11
Lee, Ho-Young; Chang, Yoon Soo; Han, Ji-Youn et al. (2005) Effects of 9-cis-retinoic acid on the insulin-like growth factor axis in former smokers. J Clin Oncol 23:4439-49
Wu, Xifeng; Roth, Jack A; Zhao, Hua et al. (2005) Cell cycle checkpoints, DNA damage/repair, and lung cancer risk. Cancer Res 65:349-57
Tang, Ximing; Wu, Weiguo; Sun, Shi-Yong et al. (2004) Hypermethylation of the death-associated protein kinase promoter attenuates the sensitivity to TRAIL-induced apoptosis in human non-small cell lung cancer cells. Mol Cancer Res 2:685-91
Lu, Tao; Hittelman, Walter N (2004) Improvement and application of fluorescence inter-simple sequence repeat polymerase chain reaction for the study of subclonal growths in lung epithelial cell populations. Chest 125:110S-1S
Wu, Xifeng; Zhao, Hua; Wei, Qingyi et al. (2003) XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. Carcinogenesis 24:505-9
Lam, Stephen; Xu, Xiaochun; Parker-Klein, Helga et al. (2003) Surrogate end-point biomarker analysis in a retinol chemoprevention trial in current and former smokers with bronchial dysplasia. Int J Oncol 23:1607-13

Showing the most recent 10 out of 80 publications